# Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

> **NCT06852950** · NA · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Type 1 Diabetes Mellitus (T1DM)
- Hyperglycemia

## Interventions

- **DEVICE:** Libre 3 Plus Continuous Glucose Monitor
- **DEVICE:** Dexcom G7 Continuous Glucose Monitor

## Key facts

- **NCT ID:** NCT06852950
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-09
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06852950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06852950, "Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06852950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*